It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Localized cartilage lesions in early osteoarthritis and acute joint injuries are usually treated surgically to restore function and relieve pain. However, a persistent clinical challenge remains in how to repair the cartilage lesions. We expressed doublecortin (DCX) in human adipose-derived stromal/stem cells (hASCs) and engineered hASCs into cartilage tissues using an in vitro 96-well pellet culture system. The cartilage tissue constructs with and without DCX expression were implanted in the knee cartilage defects of rabbits (n = 42) and monkeys (n = 12). Cohorts of animals were euthanized at 6, 12, and 24 months after surgery to evaluate the cartilage repair outcomes. We found that DCX expression in hASCs increased expression of growth differentiation factor 5 (GDF5) and matrilin 2 in the engineered cartilage tissues. The cartilage tissues with DCX expression significantly enhanced cartilage repair as assessed macroscopically and histologically at 6, 12, and 24 months after implantation in the rabbits and 24 months after implantation in the monkeys, compared to the cartilage tissues without DCX expression. These findings suggest that hASCs expressing DCX may be engineered into cartilage tissues that can be used to treat localized cartilage lesions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Tulane University School of Medicine, Department of Structural and Cellular Biology, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Tulane University School of Medicine, Department of Orthopaedic Surgery, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
2 Tulane University School of Medicine, Department of Orthopaedic Surgery, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
3 Tulane University School of Medicine, Department of Structural and Cellular Biology, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); LaCell LLC and Obatala Sciences Inc., New Orleans, USA (GRID:grid.504745.7); Tulane University School of Medicine, Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Tulane University School of Medicine, John W. Deming Department of Medicine, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Tulane University School of Medicine, Department of Surgery, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
4 LaCell LLC and Obatala Sciences Inc., New Orleans, USA (GRID:grid.504745.7)
5 Tulane University, Tulane National Primate Research Center, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
6 Tulane University, Department of Biomedical Engineering, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
7 Tulane University School of Medicine, Department of Pathology and Laboratory Medicine, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
8 Tulane University School of Public Health and Tropic Medicine, Department of Biostatistics and Data Science, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588)
9 Tulane University School of Medicine, Department of Structural and Cellular Biology, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Tulane University School of Medicine, Department of Orthopaedic Surgery, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Tulane University School of Medicine, Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Tulane University School of Medicine, Tulane Cancer Center and Louisiana Cancer Research Consortium, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Tulane University School of Medicine, Tulane Center for Aging, New Orleans, USA (GRID:grid.265219.b) (ISNI:0000 0001 2217 8588); Southeast Louisiana Veterans Health Care System, New Orleans, USA (GRID:grid.417056.1) (ISNI:0000 0004 0419 6004)